血液黏度计市场（2026—2031）
血液黏度计市场规模预计由2026年的18.4亿美元增至2031年的24.4亿美元，预测期复合年增长率为5.83%。北美是当前最大市场，亚太地区增长最快。
市场研究正文
规模、增长、细分、驱动因素与关键问题
当前质量分 100.00，审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。
核心结论
血液黏度计市场规模预计由2026年的18.4亿美元增至2031年的24.4亿美元，预测期复合年增长率为5.83%。北美是当前最大市场，亚太地区增长最快。
市场走势
结构化指标
| 指标 | 年份 | 数值 | 性质 |
|---|---|---|---|
| 复合年增长率 | 2031 | 5.83% | 机构预测 |
| 市场规模 | 2026 | USD 1.84 billion | 机构预测 |
| 市场规模 | 2031 | USD 2.44 billion | 机构预测 |
细分市场份额
市场结构
| 维度 | 细分项 | 年份 | 份额 |
|---|---|---|---|
| application | clinical diagnostics and patient monitoring | 2025 | 42.510% |
| geography | North America | 2025 | 35.730% |
| product_type | rotational viscometers | 2025 | 38.940% |
关键结论
- application 维度中，clinical diagnostics and patient monitoring 在 2025 年的公开份额为 42.51%。
- geography 维度中，North America 在 2025 年的公开份额为 35.73%。
- product_type 维度中，rotational viscometers 在 2025 年的公开份额为 38.94%。
主要参与者
- AMETEK Brookfield
- Anton Paar GmbH
- Cannon Instrument Company
- Thermo Fisher Scientific Inc.
- LAUDA Scientific GmbH
增长驱动因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Rising Cardiovascular and Metabolic Disease Burden | +1.800% | Global | Short term (≤ 2 years) |
| Growing Hematological and Hyperviscosity Disorders | +0.900% | Global, concentrated in North America and Europe | Medium term (2-4 years) |
| Automated and Digital Laboratory Workflows | +1.100% | North America and Europe, spill-over to Asia-Pacific | Medium term (2-4 years) |
| Point-of-Care and Decentralized Diagnostics | +0.700% | Asia-Pacific core, spill-over to the Middle East, Africa, and South America | Short term (≤ 2 years) |
| Microfluidic Low-Volume and High-Shear Testing | +0.600% | North America, Europe, and Asia-Pacific | Long term (≥ 4 years) |
| Clinical Translation of Viscosity as A Hemodynamic Biomarker | +0.500% | Global | Long term (≥ 4 years) |
市场制约因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Instrument, Calibration, and Maintenance Costs | -1.200% | Global, most acute in emerging markets and community hospitals | Medium term (2-4 years) |
| Limited Clinical Standardization and Reimbursement | -0.900% | North America and Europe for reimbursement, global for standardization | Long term (≥ 4 years) |
| Shortage of Skilled Operators and Application Support | -0.500% | Emerging markets in Asia-Pacific, the Middle East, Africa, and South America | Medium term (2-4 years) |
| Pre-Analytical Sensitivity of Whole-Blood Samples | -0.400% | Global | Short term (≤ 2 years) |
报告关注的关键问题
What is the projected value of the blood viscometer market by 2031?
The blood viscometer market is forecast to reach USD 2.44 billion by 2031, growing from USD 1.84 billion in 2026 at a 5.83% CAGR. Demand is supported by broader clinical use in cardiovascular, metabolic, neurological, and hematology settings, as facilities seek measurements that can complement established clinical and laboratory markers.
Which blood viscometer product type held the largest share in 2025?
Rotational viscometers led product revenue with a 38.94% share in 2025 because of clinical familiarity and broad shear-rate capability. They can assess whole-blood and plasma samples in temperature-controlled laboratory workflows, which helps hospitals maintain familiar processes for routine use, training, calibration, and result review. Capillary formats are forecast to grow faster through 2031.
Which application is expanding fastest for blood viscometers?
Hematology and blood research is the fastest-growing application, with a projected 6.83% CAGR through 2031. Sickle cell monitoring, oncology, immunology, drug formulation, and clinical trial work are widening the use of viscosity measurement, particularly where longitudinal assessment or constrained sample volumes matter. These uses can support repeated testing across research programs.
Why are automated blood viscometers gaining adoption?
Automated systems can reduce manual work, support audit trails, and improve reporting through laboratory information system connectivity. They are particularly relevant to high-volume laboratories that need stable measurements, documented processes, and repeatable quality control, while reducing the effort associated with manual data transfer and review. Data integrity requirements also influence selection in regulated laboratories.
Which region is forecast to grow fastest through 2031?
Asia-Pacific is projected to grow at an 8.27% CAGR through 2031, supported by hospital investment and rising chronic disease incidence. Growth also reflects decentralized diagnostic needs across China, India, South Korea, Japan, and other regional markets, where infrastructure investment is widening access to laboratory automation and point-of-care testing. Public hospital upgrading programs are important to this expansion.
What limits wider use of blood-viscosity testing?
Instrument ownership costs, limited protocol standardization, reimbursement gaps, operator shortages, and pre-analytical sensitivity remain key constraints. These factors affect procurement decisions, the comparability of results, and the ability of smaller facilities to maintain consistent testing workflows, especially when reimbursement or specialized technical support is unavailable. Better protocols and service access would address part of this constraint.
市场概览
- 增长最快市场：亚太地区
- 最大市场：北美
- 市场集中度：中等
查看来源：Mordor Intelligence